Noxa expression has been shown to be dysregulated in tumours such as colorectal cancer39, pancreatic cancer40, human adenoid cystic carcinoma41, and breast cancer42.Noxa is now being tested as a promising therapeutic target in cancer biology. This evidence concerns the gene PMAIP1 and neoplasm.